Early diagnosis coupled with aggressive treatment is important to achieve an optimal outcome in a patient with inflammatory arthritis. The expert nationally-recognized faculty will discuss both similarities and differences in the pathogenetic mechanisms that underlie inflammatory arthritis, focusing on rheumatoid arthritis (RA) and the spondyloarthropathies. Topics will also include biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDS and tsDMARDS), strategies to enable the rational selection of therapeutic agents for the treatment of an individual patient, novel developments in clinical areas related to optimum treatment plans, and an update on checkpoint inhibitor associated arthritis. Please join us for this 2-day event!

 TARGET AUDIENCE

This activity is targeted to rheumatologists, residents, and fellows.

ACCREDITATION AND CREDIT DESIGNATION

Hospital for Special Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Hospital for Special Surgery designates this live activity for a maximum of 12.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.